Evaluation of the Demographic and Laboratory Data of PatientsDiagnosed with Crimean-Congo Hemorrhagic Fever in theEmergency Department and Their Relationship with Morbidityand Mortality
The complete blood count, liver-renal enzymes, electrolytes, prothrombin time, activated partial thromboplastin time (aPTT), D-dimer values, fibrinogen values, and international normalized ratio (INR) were recorded and analyzed at admission.Results: Non-survivors had higher levels of alkaline phosphatase, alanine aminotransferase, amylase, aspartate aminotransferase (AST), blood urea nitrogen (BUN), direct bilirubin, gamma-glutamyl transferase, creatinine, potassium, total bilirubin and uric acid (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: Crimean-Congo hemorrhagic fever (CCHF) is transmitted by infected ticks or through contaminated blood, tissue, and body fluids.
📊
Key Findings & Data:Pathological laboratory results, such as thrombocytopenia, leukopenia, and anemia, along with biochemistry and coagulation parameters, can be used for its diagnosis and the determination of its prognosis.Materials and Methods: Data of patients over 17 years of age diagnosed with CCHF between 2013 and 2018 were reviewed retrospectively.
💡
Conclusion & Impact:The complete blood count, liver-renal enzymes, electrolytes, prothrombin time, activated partial thromboplastin time (aPTT), D-dimer values, fibrinogen values, and international normalized ratio (INR) were recorded and analyzed at admission.Results: Non-survivors had higher levels of alkaline phosphatase, alanine aminotransferase, amylase, aspartate aminotransferase (AST), blood urea nitrogen (BUN), direct bilirubin, gamma-glutamyl transferase, creatinine, potassium, total bilirubin and uric acid (p
🔬Design:Review & Systematic Survey
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters
Abstract
Aim: Crimean-Congo hemorrhagic fever (CCHF) is transmitted by infected ticks or through contaminated blood, tissue, and body fluids. Pathological laboratory results, such as thrombocytopenia, leukopenia, and anemia, along with biochemistry and coagulation parameters, can be used for its diagnosis and the determination of its prognosis.Materials and Methods: Data of patients over 17 years of age diagnosed with CCHF between 2013 and 2018 were reviewed retrospectively. The complete blood count, liver-renal enzymes, electrolytes, prothrombin time, activated partial thromboplastin time (aPTT), D-dimer values, fibrinogen values, and international normalized ratio (INR) were recorded and analyzed at admission.Results: Non-survivors had higher levels of alkaline phosphatase, alanine aminotransferase, amylase, aspartate aminotransferase (AST), blood urea nitrogen (BUN), direct bilirubin, gamma-glutamyl transferase, creatinine, potassium, total bilirubin and uric acid (p
🔖
Cite This Article
BÜYÜKTUNA, S. A., Soylu, Ü., DEMIRTAS, E., korkmaz, I., TEKİN, Y. K., Yurtbay, S. (2022). Evaluation of the Demographic and Laboratory Data of PatientsDiagnosed with Crimean-Congo Hemorrhagic Fever in theEmergency Department and Their Relationship with Morbidityand Mortality. Eurasian Journal of Emergency Medicine, Cilt: 20 - Sayı: 1, 12–18. https://ajindex.com/articles/507903
Ergönül Ö. Kırım Kongo kanamalı ateşi. ANKEM Derg. 2009;23:234-40
Bakır M. Kırım Kongo hemorajik ateşi. ANKEM Derg. 2004;18:90-3
Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203- 14
Bodur H. Kırım-Kongo kanamalı ateşi ve DAS yönetimi
Ulusal Sterilizasyon Dezenfeksiyon Kongresi; 2007 Nisan 4-8; Kundu, Antalya, Türkiye; 2007.p.509-20
Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11:794-800
Liu, Dongyou, editor. Manual of security sensitive microbes and toxins. CRC Press. 2014.p.37-52
Akıncı E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic Fever: Vector Borne Zoonotic Dis. 2013;13:429-37
Bray M. Comparative pathogenesis of Crimean Congo hemorrhagic fever and Ebola hemorrhagic fever. In: Ergonul O, Whitehouse CA. Dordrecht, NL, editors. Crimean Congo Hemorrhagic Fever: A Global Perspective: Springer. 2007.p.221-31
Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006;193:941- 4
Özkurt Z. Kırım Kongo Kanamalı Ateşi. Yoğun Bakım Derg. 2007;7:85-90
Eren SH, Korkmaz İ, Aktas C, Ay D. Diagnostic criteria in Crimean Congo haemorrhagic fever disease and cost analysis. Afr J Microbiol Res. 2010;4:646- 9
Öngörü P, Dagdas S, Bodur H, Yilmaz M, Akinci E, Eren S, et al. Coagulopathy parameters in patients with Crimean-Congo Hemorrhagic fever and its relation with mortality. J Clin Lab Anal. 2010;24:163-6
Karakecili F, Cikman A, Aydın M, Binay UD, Kesik OA, Özçiçek F. Evaluation of epidemiological, clinical, and laboratory characteristics and mortality rate of patients with Crimean-Congo hemorrhagic fever in the northeast region of Turkey J Vector Borne Dis. 2018;55:215-21
Hatipoglu CA, Bulut C, Yetkin MA, Ertem GT, Erdinc FS, Kilic EK, et al. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand J Infect Dis. 2010;42:516-21
Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F. The effectiveness of routine laboratory findings in determining disease severityin patients with Crimean-Congo hemorrhagic fever: Severity prediction criteria J Clin Virol. 2010;47:361-5